APO Research
Talk to an analyst

APO RESEARCH · REPORT

FAPI for Tumor Diagnosis

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global FAPI for Tumor Diagnosis Industry Growth and Trends Forecast to 2032

28 December 202597 pages

Choose your research edition.

Industry ResearchFAPI for Tumor Diagnosis Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal FAPI for Tumor Diagnosis Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal FAPI for Tumor Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal FAPI for Tumor Diagnosis Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal FAPI for Tumor Diagnosis Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global FAPI for Tumor Diagnosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for FAPI for Tumor Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for FAPI for Tumor Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for FAPI for Tumor Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of FAPI for Tumor Diagnosis include SOFIE, Ferronova, GE HealthCare, Isotopia and Lantheus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global FAPI for Tumor Diagnosis market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The FAPI for Tumor Diagnosis market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global FAPI for Tumor Diagnosis market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to FAPI for Tumor Diagnosis.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global FAPI for Tumor Diagnosis market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

FAPI for Tumor Diagnosis Market by Company

SOFIE

Ferronova

GE HealthCare

Isotopia

Lantheus

FAPI for Tumor Diagnosis Segment by Type

Ga-labeled

F-labeled

Other

FAPI for Tumor Diagnosis Segment by Application

NSCLC

Pancreatic Cancer

Breast Cancer

Others

FAPI for Tumor Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global FAPI for Tumor Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of FAPI for Tumor Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of FAPI for Tumor Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of FAPI for Tumor Diagnosis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of FAPI for Tumor Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Ga-labeled Table 2. Major Company of F-labeled Table 3. Major Company of Other Table 4. Global FAPI for Tumor Diagnosis Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global FAPI for Tumor Diagnosis Sales by Type (2021-2026) & (K Units) Table 6. Global FAPI for Tumor Diagnosis Sales Market Share in Volume by Type (2021-2026) Table 7. Global FAPI for Tumor Diagnosis Sales by Type (2021-2026) & (US$ Million) Table 8. Global FAPI for Tumor Diagnosis Sales Market Share in Value by Type (2021-2026) Table 9. Global FAPI for Tumor Diagnosis Price by Type (2021-2026) & (US$/Unit) Table 10. Global FAPI for Tumor Diagnosis Sales by Type (2027-2032) & (K Units) Table 11. Global FAPI for Tumor Diagnosis Sales Market Share in Volume by Type (2027-2032) Table 12. Global FAPI for Tumor Diagnosis Sales by Type (2027-2032) & (US$ Million) Table 13. Global FAPI for Tumor Diagnosis Sales Market Share in Value by Type (2027-2032) Table 14. Global FAPI for Tumor Diagnosis Price by Type (2027-2032) & (US$/Unit) Table 15. North America FAPI for Tumor Diagnosis Sales by Type (2021-2026) & (K Units) Table 16. North America FAPI for Tumor Diagnosis Sales by Type (2021-2026) & (US$ Million) Table 17. Europe FAPI for Tumor Diagnosis Sales by Type (2021-2026) & (K Units) Table 18. Europe FAPI for Tumor Diagnosis Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific FAPI for Tumor Diagnosis Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific FAPI for Tumor Diagnosis Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America FAPI for Tumor Diagnosis Sales by Type (2021-2026) & (K Units) Table 22. Latin America FAPI for Tumor Diagnosis Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa FAPI for Tumor Diagnosis Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa FAPI for Tumor Diagnosis Sales by Type (2021-2026) & (US$ Million) Table 25. FAPI for Tumor Diagnosis Industry Trends Table 26. FAPI for Tumor Diagnosis Industry Drivers Table 27. FAPI for Tumor Diagnosis Industry Opportunities and Challenges Table 28. FAPI for Tumor Diagnosis Industry Restraints Table 29. Global FAPI for Tumor Diagnosis Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global FAPI for Tumor Diagnosis Revenue Market Share by Company (2021-2026) Table 31. Global FAPI for Tumor Diagnosis Sales by Company (2021-2026) & (K Units) Table 32. Global FAPI for Tumor Diagnosis Sales Share by Company (2021-2026) Table 33. Global FAPI for Tumor Diagnosis Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global FAPI for Tumor Diagnosis Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global FAPI for Tumor Diagnosis Major Company Production Sites and Headquarters Table 36. Global FAPI for Tumor Diagnosis Company, Product Type & Application Table 37. Global FAPI for Tumor Diagnosis Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global FAPI for Tumor Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global FAPI for Tumor Diagnosis Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global FAPI for Tumor Diagnosis Sales by Region (2021-2026) & (K Units) Table 42. Global FAPI for Tumor Diagnosis Sales Market Share in Volume by Region (2021-2026) Table 43. Global FAPI for Tumor Diagnosis Sales by Region (2021-2026) & (US$ Million) Table 44. Global FAPI for Tumor Diagnosis Sales Market Share in Value by Region (2021-2026) Table 45. Global FAPI for Tumor Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global FAPI for Tumor Diagnosis Sales by Region (2027-2032) & (K Units) Table 47. Global FAPI for Tumor Diagnosis Sales Market Share in Volume by Region (2027-2032) Table 48. Global FAPI for Tumor Diagnosis Sales by Region (2027-2032) & (US$ Million) Table 49. Global FAPI for Tumor Diagnosis Sales Market Share in Value by Region (2027-2032) Table 50. Global FAPI for Tumor Diagnosis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global FAPI for Tumor Diagnosis Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global FAPI for Tumor Diagnosis Sales by Application (2021-2026) & (K Units) Table 53. Global FAPI for Tumor Diagnosis Sales Market Share in Volume by Application (2021-2026) Table 54. Global FAPI for Tumor Diagnosis Sales by Application (2021-2026) & (US$ Million) Table 55. Global FAPI for Tumor Diagnosis Sales Market Share in Value by Application (2021-2026) Table 56. Global FAPI for Tumor Diagnosis Price by Application (2021-2026) & (US$/Unit) Table 57. Global FAPI for Tumor Diagnosis Sales by Application (2027-2032) & (K Units) Table 58. Global FAPI for Tumor Diagnosis Sales Market Share in Volume by Application (2027-2032) Table 59. Global FAPI for Tumor Diagnosis Sales by Application (2027-2032) & (US$ Million) Table 60. Global FAPI for Tumor Diagnosis Sales Market Share in Value by Application (2027-2032) Table 61. Global FAPI for Tumor Diagnosis Price by Application (2027-2032) & (US$/Unit) Table 62. North America FAPI for Tumor Diagnosis Sales by Application (2021-2026) & (K Units) Table 63. North America FAPI for Tumor Diagnosis Sales by Application (2021-2026) & (US$ Million) Table 64. Europe FAPI for Tumor Diagnosis Sales by Application (2021-2026) & (K Units) Table 65. Europe FAPI for Tumor Diagnosis Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific FAPI for Tumor Diagnosis Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific FAPI for Tumor Diagnosis Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America FAPI for Tumor Diagnosis Sales by Application (2021-2026) & (K Units) Table 69. Latin America FAPI for Tumor Diagnosis Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa FAPI for Tumor Diagnosis Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa FAPI for Tumor Diagnosis Sales by Application (2021-2026) & (US$ Million) Table 72. SOFIE Company Information Table 73. SOFIE Business Overview Table 74. SOFIE FAPI for Tumor Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. SOFIE FAPI for Tumor Diagnosis Product Portfolio Table 76. SOFIE Recent Development Table 77. Ferronova Company Information Table 78. Ferronova Business Overview Table 79. Ferronova FAPI for Tumor Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Ferronova FAPI for Tumor Diagnosis Product Portfolio Table 81. Ferronova Recent Development Table 82. GE HealthCare Company Information Table 83. GE HealthCare Business Overview Table 84. GE HealthCare FAPI for Tumor Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. GE HealthCare FAPI for Tumor Diagnosis Product Portfolio Table 86. GE HealthCare Recent Development Table 87. Isotopia Company Information Table 88. Isotopia Business Overview Table 89. Isotopia FAPI for Tumor Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Isotopia FAPI for Tumor Diagnosis Product Portfolio Table 91. Isotopia Recent Development Table 92. Lantheus Company Information Table 93. Lantheus Business Overview Table 94. Lantheus FAPI for Tumor Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Lantheus FAPI for Tumor Diagnosis Product Portfolio Table 96. Lantheus Recent Development Table 97. North America FAPI for Tumor Diagnosis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 98. North America FAPI for Tumor Diagnosis Sales by Country (2021-2026) & (K Units) Table 99. North America FAPI for Tumor Diagnosis Sales Market Share by Country (2021-2026) Table 100. North America FAPI for Tumor Diagnosis Sales Forecast by Country (2027-2032) & (K Units) Table 101. North America FAPI for Tumor Diagnosis Sales Market Share Forecast by Country (2027-2032) Table 102. North America FAPI for Tumor Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. North America FAPI for Tumor Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 104. North America FAPI for Tumor Diagnosis Market Share by Country (2021-2026) Table 105. North America FAPI for Tumor Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. North America FAPI for Tumor Diagnosis Market Share Forecast by Country (2027-2032) Table 107. Europe FAPI for Tumor Diagnosis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. Europe FAPI for Tumor Diagnosis Sales by Country (2021-2026) & (K Units) Table 109. Europe FAPI for Tumor Diagnosis Sales Market Share by Country (2021-2026) Table 110. Europe FAPI for Tumor Diagnosis Sales Forecast by Country (2027-2032) & (K Units) Table 111. Europe FAPI for Tumor Diagnosis Sales Market Share Forecast by Country (2027-2032) Table 112. Europe FAPI for Tumor Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Europe FAPI for Tumor Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 114. Europe FAPI for Tumor Diagnosis Market Share by Country (2021-2026) Table 115. Europe FAPI for Tumor Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Europe FAPI for Tumor Diagnosis Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific FAPI for Tumor Diagnosis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific FAPI for Tumor Diagnosis Sales by Country (2021-2026) & (K Units) Table 119. Asia-Pacific FAPI for Tumor Diagnosis Sales Market Share by Country (2021-2026) Table 120. Asia-Pacific FAPI for Tumor Diagnosis Sales Forecast by Country (2027-2032) & (K Units) Table 121. Asia-Pacific FAPI for Tumor Diagnosis Sales Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific FAPI for Tumor Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific FAPI for Tumor Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 124. Asia-Pacific FAPI for Tumor Diagnosis Market Share by Country (2021-2026) Table 125. Asia-Pacific FAPI for Tumor Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Asia-Pacific FAPI for Tumor Diagnosis Market Share Forecast by Country (2027-2032) Table 127. Latin America FAPI for Tumor Diagnosis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Latin America FAPI for Tumor Diagnosis Sales by Country (2021-2026) & (K Units) Table 129. Latin America FAPI for Tumor Diagnosis Sales Market Share by Country (2021-2026) Table 130. Latin America FAPI for Tumor Diagnosis Sales Forecast by Country (2027-2032) & (K Units) Table 131. Latin America FAPI for Tumor Diagnosis Sales Market Share Forecast by Country (2027-2032) Table 132. Latin America FAPI for Tumor Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Latin America FAPI for Tumor Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 134. Latin America FAPI for Tumor Diagnosis Market Share by Country (2021-2026) Table 135. Latin America FAPI for Tumor Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Latin America FAPI for Tumor Diagnosis Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa FAPI for Tumor Diagnosis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa FAPI for Tumor Diagnosis Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa FAPI for Tumor Diagnosis Sales Market Share by Country (2021-2026) Table 140. Middle East and Africa FAPI for Tumor Diagnosis Sales Forecast by Country (2027-2032) & (K Units) Table 141. Middle East and Africa FAPI for Tumor Diagnosis Sales Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa FAPI for Tumor Diagnosis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa FAPI for Tumor Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 144. Middle East and Africa FAPI for Tumor Diagnosis Market Share by Country (2021-2026) Table 145. Middle East and Africa FAPI for Tumor Diagnosis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Middle East and Africa FAPI for Tumor Diagnosis Market Share Forecast by Country (2027-2032) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. FAPI for Tumor Diagnosis Distributors List Table 150. FAPI for Tumor Diagnosis Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. FAPI for Tumor Diagnosis Image Figure 2. Global FAPI for Tumor Diagnosis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global FAPI for Tumor Diagnosis Market Size (2021-2032) & (US$ Million) Figure 4. Global FAPI for Tumor Diagnosis Sales (2021-2032) & (K Units) Figure 5. Ga-labeled Image Figure 6. Global Ga-labeled Sales YoY Growth (2021-2032) & (K Units) Figure 7. F-labeled Image Figure 8. Global F-labeled Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global FAPI for Tumor Diagnosis Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global FAPI for Tumor Diagnosis Market Share by Type 2025 VS 2032 Figure 13. North America FAPI for Tumor Diagnosis Sales Market Share in Volume by Type in 2025 Figure 14. North America FAPI for Tumor Diagnosis Sales Market Share in Value by Type in 2025 Figure 15. Europe FAPI for Tumor Diagnosis Sales Market Share in Volume by Type in 2025 Figure 16. Europe FAPI for Tumor Diagnosis Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific FAPI for Tumor Diagnosis Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific FAPI for Tumor Diagnosis Sales Market Share in Value by Type in 2025 Figure 19. Latin America FAPI for Tumor Diagnosis Sales Market Share in Volume by Type in 2025 Figure 20. Latin America FAPI for Tumor Diagnosis Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa FAPI for Tumor Diagnosis Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa FAPI for Tumor Diagnosis Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 FAPI for Tumor Diagnosis Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. NSCLC Image Figure 26. Global NSCLC Sales YoY Growth (2021-2032) & (K Units) Figure 27. Pancreatic Cancer Image Figure 28. Global Pancreatic Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 29. Breast Cancer Image Figure 30. Global Breast Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global FAPI for Tumor Diagnosis Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global FAPI for Tumor Diagnosis Market Share by Application 2025 VS 2032 Figure 35. North America FAPI for Tumor Diagnosis Sales Market Share in Volume by Application in 2025 Figure 36. North America FAPI for Tumor Diagnosis Sales Market Share in Value by Application in 2025 Figure 37. Europe FAPI for Tumor Diagnosis Sales Market Share in Volume by Application in 2025 Figure 38. Europe FAPI for Tumor Diagnosis Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific FAPI for Tumor Diagnosis Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific FAPI for Tumor Diagnosis Sales Market Share in Value by Application in 2025 Figure 41. Latin America FAPI for Tumor Diagnosis Sales Market Share in Volume by Application in 2025 Figure 42. Latin America FAPI for Tumor Diagnosis Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa FAPI for Tumor Diagnosis Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa FAPI for Tumor Diagnosis Sales Market Share in Value by Application in 2025 Figure 45. North America FAPI for Tumor Diagnosis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America FAPI for Tumor Diagnosis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America FAPI for Tumor Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America FAPI for Tumor Diagnosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe FAPI for Tumor Diagnosis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe FAPI for Tumor Diagnosis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe FAPI for Tumor Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe FAPI for Tumor Diagnosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific FAPI for Tumor Diagnosis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific FAPI for Tumor Diagnosis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific FAPI for Tumor Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific FAPI for Tumor Diagnosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America FAPI for Tumor Diagnosis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America FAPI for Tumor Diagnosis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America FAPI for Tumor Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America FAPI for Tumor Diagnosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa FAPI for Tumor Diagnosis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa FAPI for Tumor Diagnosis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa FAPI for Tumor Diagnosis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa FAPI for Tumor Diagnosis Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. FAPI for Tumor Diagnosis Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. FAPI for Tumor Diagnosis Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Ga-labeled
  • F-labeled
  • Other
Applications
  • NSCLC
  • Pancreatic Cancer
  • Breast Cancer
  • Others
Companies covered
  • SOFIE
  • Ferronova
  • GE HealthCare
  • Isotopia
  • Lantheus

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global FAPI for Tumor Diagnosis Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global FAPI for Tumor Diagnosis Sales Estimates and Forecasts (2021-2032)
  5. 1.3 FAPI for Tumor Diagnosis Market by Type
  6. 1.3.1 Ga-labeled
  7. 1.3.2 F-labeled
  8. 1.3.3 Other
  9. 1.4 Global FAPI for Tumor Diagnosis Market Size by Type
  10. 1.4.1 Global FAPI for Tumor Diagnosis Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global FAPI for Tumor Diagnosis Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global FAPI for Tumor Diagnosis Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America FAPI for Tumor Diagnosis Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe FAPI for Tumor Diagnosis Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific FAPI for Tumor Diagnosis Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America FAPI for Tumor Diagnosis Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa FAPI for Tumor Diagnosis Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 FAPI for Tumor Diagnosis Industry Trends
  2. 2.2 FAPI for Tumor Diagnosis Industry Drivers
  3. 2.3 FAPI for Tumor Diagnosis Industry Opportunities and Challenges
  4. 2.4 FAPI for Tumor Diagnosis Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by FAPI for Tumor Diagnosis Revenue (2021-2026)
  2. 3.2 Global Top Players by FAPI for Tumor Diagnosis Sales (2021-2026)
  3. 3.3 Global Top Players by FAPI for Tumor Diagnosis Price (2021-2026)
  4. 3.4 Global FAPI for Tumor Diagnosis Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global FAPI for Tumor Diagnosis Major Company Production Sites & Headquarters
  6. 3.6 Global FAPI for Tumor Diagnosis Company, Product Type & Application
  7. 3.7 Global FAPI for Tumor Diagnosis Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global FAPI for Tumor Diagnosis Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 FAPI for Tumor Diagnosis Players Market Share by Revenue in 2025
  11. 3.8.3 2025 FAPI for Tumor Diagnosis Tier 1, Tier 2, and Tier 3
4 FAPI for Tumor Diagnosis Regional Status and Outlook
  1. 4.1 Global FAPI for Tumor Diagnosis Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global FAPI for Tumor Diagnosis Historic Market Size by Region
  3. 4.2.1 Global FAPI for Tumor Diagnosis Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global FAPI for Tumor Diagnosis Sales in Value by Region (2021-2026)
  5. 4.2.3 Global FAPI for Tumor Diagnosis Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global FAPI for Tumor Diagnosis Forecasted Market Size by Region
  7. 4.3.1 Global FAPI for Tumor Diagnosis Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global FAPI for Tumor Diagnosis Sales in Value by Region (2027-2032)
  9. 4.3.3 Global FAPI for Tumor Diagnosis Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 FAPI for Tumor Diagnosis by Application
  1. 5.1 FAPI for Tumor Diagnosis Market by Application
  2. 5.1.1 NSCLC
  3. 5.1.2 Pancreatic Cancer
  4. 5.1.3 Breast Cancer
  5. 5.1.4 Others
  6. 5.2 Global FAPI for Tumor Diagnosis Market Size by Application
  7. 5.2.1 Global FAPI for Tumor Diagnosis Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global FAPI for Tumor Diagnosis Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global FAPI for Tumor Diagnosis Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America FAPI for Tumor Diagnosis Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe FAPI for Tumor Diagnosis Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific FAPI for Tumor Diagnosis Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America FAPI for Tumor Diagnosis Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa FAPI for Tumor Diagnosis Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 SOFIE
  2. 6.1.1 SOFIE Company Information
  3. 6.1.2 SOFIE Business Overview
  4. 6.1.3 SOFIE FAPI for Tumor Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 SOFIE FAPI for Tumor Diagnosis Product Portfolio
  6. 6.1.5 SOFIE Recent Developments
  7. 6.2 Ferronova
  8. 6.2.1 Ferronova Company Information
  9. 6.2.2 Ferronova Business Overview
  10. 6.2.3 Ferronova FAPI for Tumor Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Ferronova FAPI for Tumor Diagnosis Product Portfolio
  12. 6.2.5 Ferronova Recent Developments
  13. 6.3 GE HealthCare
  14. 6.3.1 GE HealthCare Company Information
  15. 6.3.2 GE HealthCare Business Overview
  16. 6.3.3 GE HealthCare FAPI for Tumor Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GE HealthCare FAPI for Tumor Diagnosis Product Portfolio
  18. 6.3.5 GE HealthCare Recent Developments
  19. 6.4 Isotopia
  20. 6.4.1 Isotopia Company Information
  21. 6.4.2 Isotopia Business Overview
  22. 6.4.3 Isotopia FAPI for Tumor Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Isotopia FAPI for Tumor Diagnosis Product Portfolio
  24. 6.4.5 Isotopia Recent Developments
  25. 6.5 Lantheus
  26. 6.5.1 Lantheus Company Information
  27. 6.5.2 Lantheus Business Overview
  28. 6.5.3 Lantheus FAPI for Tumor Diagnosis Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lantheus FAPI for Tumor Diagnosis Product Portfolio
  30. 6.5.5 Lantheus Recent Developments
7 North America by Country
  1. 7.1 North America FAPI for Tumor Diagnosis Sales by Country
  2. 7.1.1 North America FAPI for Tumor Diagnosis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America FAPI for Tumor Diagnosis Sales by Country (2021-2026)
  4. 7.1.3 North America FAPI for Tumor Diagnosis Sales Forecast by Country (2027-2032)
  5. 7.2 North America FAPI for Tumor Diagnosis Market Size by Country
  6. 7.2.1 North America FAPI for Tumor Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America FAPI for Tumor Diagnosis Market Size by Country (2021-2026)
  8. 7.2.3 North America FAPI for Tumor Diagnosis Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe FAPI for Tumor Diagnosis Sales by Country
  2. 8.1.1 Europe FAPI for Tumor Diagnosis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe FAPI for Tumor Diagnosis Sales by Country (2021-2026)
  4. 8.1.3 Europe FAPI for Tumor Diagnosis Sales Forecast by Country (2027-2032)
  5. 8.2 Europe FAPI for Tumor Diagnosis Market Size by Country
  6. 8.2.1 Europe FAPI for Tumor Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe FAPI for Tumor Diagnosis Market Size by Country (2021-2026)
  8. 8.2.3 Europe FAPI for Tumor Diagnosis Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific FAPI for Tumor Diagnosis Sales by Country
  2. 9.1.1 Asia-Pacific FAPI for Tumor Diagnosis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific FAPI for Tumor Diagnosis Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific FAPI for Tumor Diagnosis Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific FAPI for Tumor Diagnosis Market Size by Country
  6. 9.2.1 Asia-Pacific FAPI for Tumor Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific FAPI for Tumor Diagnosis Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific FAPI for Tumor Diagnosis Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America FAPI for Tumor Diagnosis Sales by Country
  2. 10.1.1 South America FAPI for Tumor Diagnosis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America FAPI for Tumor Diagnosis Sales by Country (2021-2026)
  4. 10.1.3 South America FAPI for Tumor Diagnosis Sales Forecast by Country (2027-2032)
  5. 10.2 South America FAPI for Tumor Diagnosis Market Size by Country
  6. 10.2.1 South America FAPI for Tumor Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America FAPI for Tumor Diagnosis Market Size by Country (2021-2026)
  8. 10.2.3 South America FAPI for Tumor Diagnosis Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa FAPI for Tumor Diagnosis Sales by Country
  2. 11.1.1 Middle East and Africa FAPI for Tumor Diagnosis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa FAPI for Tumor Diagnosis Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa FAPI for Tumor Diagnosis Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa FAPI for Tumor Diagnosis Market Size by Country
  6. 11.2.1 Middle East and Africa FAPI for Tumor Diagnosis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa FAPI for Tumor Diagnosis Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa FAPI for Tumor Diagnosis Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 FAPI for Tumor Diagnosis Value Chain Analysis
  2. 12.1.1 FAPI for Tumor Diagnosis Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 FAPI for Tumor Diagnosis Production Mode & Process
  7. 12.2 FAPI for Tumor Diagnosis Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 FAPI for Tumor Diagnosis Distributors
  10. 12.2.3 FAPI for Tumor Diagnosis Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst